# Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors

> **NCT02439489** · PHASE1 · COMPLETED · sponsor: **Fondazione Michelangelo** · enrollment: 34 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** BKM120-CIS
- **DRUG:** BKM120-CARBO

## Key facts

- **NCT ID:** NCT02439489
- **Lead sponsor:** Fondazione Michelangelo
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2017-06-09
- **Final completion:** 2017-12-31
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02439489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02439489, "Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02439489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*